Related Experiment Video
Updated: May 29, 2026
02:52
Small Molecule Screening and Toxicity Testing in Early-stage Zebrafish Larvae
Published on: March 7, 2025
Adverse effects of serotonin depletion in developing zebrafish
Mark J Airhart1, Deborah H Lee, Tracy D Wilson
1Department of Anatomy and Cell Biology, Quillen College of Medicine, East Tennessee State University, Johnson City, TN 37614-1708, USA.
Neurotoxicology and Teratology
|September 7, 2011
Summary
Reducing serotonin (5HT) in developing zebrafish embryos with p-chlorophenylalanine (pCPA) caused paralysis and reduced body length. Myotome hypertonicity and abnormal notochord morphology were observed, affecting growth and serotonin receptor expression.
Area of Science:
- Neuroscience
- Developmental Biology
- Pharmacology
Background:
- Serotonin (5HT) plays a crucial role in vertebrate development.
- Tryptophan hydroxylase is the rate-limiting enzyme in serotonin synthesis.
- p-chlorophenylalanine (pCPA) inhibits tryptophan hydroxylase, reducing serotonin levels.
Purpose of the Study:
- To investigate the effects of reduced serotonin levels during early zebrafish development.
- To determine the impact of pCPA treatment on embryonic and larval zebrafish.
- To analyze the consequences on morphology, behavior, and gene expression.
Main Methods:
- Zebrafish embryos were treated with p-chlorophenylalanine (pCPA) to deplete serotonin.
- Immunohistochemistry was used to confirm serotonin neuron depletion.
- Morphological analysis, behavioral assays, and RT-PCR were performed.
Main Results:
- pCPA treatment led to paralysis, reduced rostrocaudal length (16-21%), and abnormal notochord morphology.
- Myotome hypertonicity contributed to decreased axial length.
- Serotonin 1A receptor (5HT(1A)) transcript levels decreased, while SERT transcript levels were affected differently in brain and spinal cord.
Conclusions:
- Reduced serotonin during early zebrafish development adversely affects body length, notochordal morphology, and locomotor behavior.
- Serotonin depletion impacts serotonin receptor and transporter gene expression.
- Myotome hypertonicity is a key factor in the observed growth deficits.
